Upgrade to SI Premium - Free Trial

Arcutis Biotherapeutics Inc. (ARQT) PT Lowered to $34 at Morgan Stanley

May 7, 2026 9:00 AM
Morgan Stanley analyst Judah Frommer ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change